Interval Partners LP Invests $7.78 Million in CME Group Inc. (NASDAQ:CME)

Interval Partners LP acquired a new stake in CME Group Inc. (NASDAQ:CME) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 36,125 shares of the financial services provider’s stock, valued at approximately $7,777,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. Gold Investment Management Ltd. acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $26,000. Northwest Financial Advisors acquired a new position in shares of CME Group during the 4th quarter worth about $28,000. Salomon & Ludwin LLC bought a new position in shares of CME Group in the 1st quarter valued at about $28,000. Harbor Investment Advisory LLC increased its position in shares of CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 145 shares during the last quarter. Finally, Rise Advisors LLC bought a new stake in CME Group during the first quarter worth about $41,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CME shares. JPMorgan Chase & Co. raised their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler dropped their price target on shares of CME Group from $235.00 to $225.00 and set an “overweight” rating on the stock in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $195.00 to $193.00 and set a “hold” rating for the company in a research report on Thursday, July 25th. Rosenblatt Securities reaffirmed a “sell” rating and issued a $187.00 target price (up from $185.00) on shares of CME Group in a report on Thursday, April 25th. Finally, Bank of America lifted their price target on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $212.64.

Insider Buying and Selling at CME Group

In related news, insider Hilda Harris Piell sold 7,140 shares of the stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the sale, the insider now owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, insider Hilda Harris Piell sold 7,140 shares of the company’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the sale, the insider now owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders sold 14,290 shares of company stock valued at $2,957,300 in the last quarter. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock traded down $1.72 on Tuesday, hitting $197.20. The stock had a trading volume of 1,712,369 shares, compared to its average volume of 1,958,286. The stock has a market cap of $71.01 billion, a price-to-earnings ratio of 22.43, a price-to-earnings-growth ratio of 6.41 and a beta of 0.52. The business’s 50 day moving average is $199.62 and its two-hundred day moving average is $207.08. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the firm posted $2.30 EPS. The company’s revenue for the quarter was up 12.7% on a year-over-year basis. Analysts forecast that CME Group Inc. will post 9.8 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were paid a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.33%. The ex-dividend date of this dividend was Friday, June 7th. CME Group’s dividend payout ratio (DPR) is 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.